Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Fr | Blueprint Medicines Corp - 8-K, Current Report | 4 | SEC Filings | ||
Fr | Bristol Myers Squibb unveils ten-year strategy to improve access to medicines in LMICs | 53 | PMLiVE | ||
Fr | Radar Therapeutics secures $13.4m to develop programmable medicines | 1 | Pharmaceutical Business Review | ||
Fr | Organon & Co.: European Medicines Agency (EMA) Validates Henlius and Organon Filings for Prolia and Xgeva (denosumab) Biosimilar Candidate HLX14 | 224 | Business Wire | Shanghai Henlius Biotech, Inc. (2696.HK) and Organon (NYSE: OGN) today announced that the European Medicines Agency (EMA) has validated the marketing authorization applications (MAAs) for HLX14, an... ► Artikel lesen | |
Di | Glenmark to market BeiGene's oncology medicines in India | 3 | Pharmaceutical Technology | ||
Di | AstraZeneca Targets $80 Bln Revenue By 2030, Plans To Launch 20 New Medicines | 175 | AFX News | LONDON (dpa-AFX) - AstraZeneca Plc. (AZN.L, AZN) aims to deliver $80 billion in total revenue by 2030, up from $45.8 billion in 2023. The target will be achieved through significant growth in... ► Artikel lesen | |
Di | Glenmark Pharma to commercialize BeiGene's oncology medicines in India | 2 | capitalmarket.com | ||
Mo | Lisata Therapeutics, Inc.: Lisata Therapeutics Receives Paediatric Investigation Plan Waiver from the European Medicines Agency for Certepetide in Pancreatic Cancer | 2 | GlobeNewswire (USA) | ||
Mo | EMA recommends suspension of 17-OHPC medicines in EU | 1 | Pharmaceutical Technology | ||
17.05. | Praxis Precision Medicines, Inc.: Praxis Precision Medicines to Participate in Upcoming Investor Conferences | 1 | GlobeNewswire (USA) | ||
16.05. | Future Market Insights: Glass Container Market to Reach USD 89.3 Billion by 2034 Amid Rising Demand for Safe Packaging Solutions for Medicines | 228 | PR Newswire | The glass container market is driven by a growing preference for sustainable and safe packaging solutions. Environmental regulations and consumer awareness are pushing the use of glass, which... ► Artikel lesen | |
16.05. | 41 medicines to get cheaper as government fixes prices of medicines and formulations | 1 | ZEE Business | ||
16.05. | AKTIONÄR-Depotwert Blueprint Medicines: "Best Idea" - neue Kaufempfehlung! | 320 | Der Aktionär | Die Aktie von Blueprint Medicines konsolidiert derzeit auf einem hohen Niveau. Trotz der starken Performance in den zurückliegenden zwölf Monaten haben die Analysten von Stephens in dieser Handelswoche... ► Artikel lesen | |
14.05. | Blueprint Medicines started at buy by Stephens, citing Ayvakit franchise | 5 | Seeking Alpha | ||
14.05. | Unveiling 18 Analyst Insights On Blueprint Medicines | 3 | Benzinga.com | ||
14.05. | AI database to bolster research for GLP1-RAs as precision medicines | 1 | Pharmaceutical Technology | ||
14.05. | Calliditas Therapeutics: Everest Medicines launches Nefecon in China | 3 | Seeking Alpha | ||
14.05. | WHO opens application period for 2025 Model Lists of Essential Medicines | 1 | PMLiVE | ||
14.05. | Calliditas Therapeutics: Calliditas' Partner Everest Medicines Starts Commercial Launch of Nefecon in China | 210 | PR Newswire | STOCKHOLM, May 14, 2024 /PRNewswire/ -- Calliditas Therapeutics AB (Nasdaq: CALT) (Nasdaq Stockholm: CALTX) ("Calliditas") today announces that its partner Everest Medicines (HKEX: 1952.HK)... ► Artikel lesen | |
14.05. | From cheaper medicines to energy bill rebates, a three-minute guide to cost-of-living relief in the budget | 1 | ABC online |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
NVIDIA | 604 |
EVOTEC | 437 |
NEL | 382 |
TUI | 356 |
GAMESTOP | 278 |
BAYER | 276 |
BIONTECH | 262 |
PLUG POWER | 231 |
DEUTSCHE LUFTHANSA | 180 |
TESLA | 180 |
RHEINMETALL | 169 |
BYD | 164 |
SIEMENS ENERGY | 146 |
VOLKSWAGEN | 140 |
SUPER MICRO COMPUTER | 139 |
DEUTSCHE BANK | 138 |
COMMERZBANK | 132 |
AMD | 117 |
MERCEDES-BENZ | 112 |
THYSSENKRUPP | 110 |
BASF | 109 |
RWE | 109 |
PAYPAL | 107 |
AIXTRON SE | 104 |
MICROSOFT | 98 |